Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Enliven Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 63
- +18 vs. Q1 2023
- Shares held
- 39.1M
- +5.53M (+16.5%) vs. Q1 2023
- Total value
- $797.9M
- +$63.0M (+8.6%) vs. Q1 2023
- New holders
- 25
- 19 more added
- Sold out
- 7
- 10 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Covestor Ltd | 1 | $0 | 0.00% | +1 | New |
| Nisa Investment Advisors, LLC | 16 | $327 | 0.00% | +16 | New |
| Baystate Wealth Management LLC | 50 | $1.02K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 81 | $1.65K | 0.00% | −253−75.7% | Reduced |
| Advisor Group Holdings, Inc. | 1,000 | $20.4K | 0.00% | +1,000 | New |
| Metropolitan Life Insurance Co | 1,279 | $26.1K | 0.00% | +1,279 | New |
| Prelude Capital Management, LLC | 33,550 | $26.8K | 0.00% | −512−1.5% | Reduced |
| Dorsey Wright & Associates | 1,375 | $28.1K | 0.01% | +138+11.2% | Added |
| Tower Research Capital LLC (TRC) | 1,382 | $28.2K | 0.00% | −275−16.6% | Reduced |
| Ameritas Investment Partners, Inc. | 1,928 | $39.4K | 0.00% | +1,928 | New |
| Amalgamated Bank | 2,270 | $46.0K | 0.00% | +2,270 | New |
| Royal Bank of Canada | 3,075 | $63.0K | 0.00% | +2,589+532.7% | Added |
| Exchange Traded Concepts, LLC | 6,934 | $141.5K | 0.00% | +6,934 | New |
| Wells Fargo & Company | 8,870 | $181.0K | 0.00% | +8,846+36,858.3% | Added |
| New York State Common Retirement Fund | 9,200 | $187.8K | 0.00% | +9,200 | New |
| Deutsche Bank AG | 9,331 | $190.4K | 0.00% | +9,331 | New |
| Denali Advisors LLC | 9,900 | $202.1K | 0.07% | +9,900 | New |
| Jane Street Group, LLC | 10,531 | $214.9K | 0.00% | −7,913−42.9% | Reduced |
| Citigroup Inc | 10,823 | $220.9K | 0.00% | −440−3.9% | Reduced |
| American International Group, Inc. | 11,235 | $229.3K | 0.00% | +11,235 | New |
| Mirae Asset Global Investments Co., Ltd. | 11,276 | $230.1K | 0.00% | +11,276 | New |
| Franklin Resources Inc | 11,685 | $238.5K | 0.00% | +11,685 | New |
| MetLife Investment Management | 12,345 | $252.0K | 0.00% | +12,345 | New |
| Barclays PLC | 14,827 | $302.6K | 0.00% | +7,600+105.2% | Added |
| Bank of America Corp | 17,043 | $347.8K | 0.00% | +10,498+160.4% | Added |
| Bridgeway Capital Management, LLC | 17,950 | $366.4K | 0.01% | 00.0% | Unchanged |
| Legal & General Group Plc | 18,055 | $368.5K | 0.00% | +18,055 | New |
| State of Wisconsin Investment Board | 22,182 | $452.7K | 0.00% | +22,182 | New |
| Dimensional Fund Advisors LP | 23,762 | $485.0K | 0.00% | +13,847+139.7% | Added |
| Credit Suisse AG | 24,055 | $491.0K | 0.00% | +24,055 | New |
| Goldman Sachs Group Inc | 27,286 | $556.9K | 0.00% | −14,125−34.1% | Reduced |
| California State Teachers Retirement System | 27,606 | $563.4K | 0.00% | +27,606 | New |
| JPMorgan Chase & Co | 30,655 | $625.7K | 0.00% | +30,561+32,511.7% | Added |
| Morgan Stanley | 33,321 | $680.1K | 0.00% | +15,903+91.3% | Added |
| Rhumbline Advisers | 34,796 | $710.2K | 0.00% | +34,796 | New |
| Renaissance Technologies LLC | 36,150 | $738.0K | 0.00% | −34,108−48.5% | Reduced |
| Swiss National Bank | 49,173 | $1.00M | 0.00% | +49,173 | New |
| JBF Capital, Inc. | 50,050 | $1.02M | 0.21% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 62,462 | $1.27M | 0.00% | +62,462 | New |
| Nuveen Asset Management, LLC | 64,695 | $1.32M | 0.00% | +64,695 | New |
| BML Capital Management, LLC | 74,232 | $1.52M | 1.36% | −137,947−65.0% | Reduced |
| Bank of New York Mellon Corp | 80,924 | $1.65M | 0.00% | +65,629+429.1% | Added |
| Acuta Capital Partners, LLC | 104,500 | $2.13M | 1.44% | +73,521+237.3% | Added |
| HighVista Strategies LLC | 121,073 | $2.47M | 1.13% | +121,073 | New |
| Bank of Montreal | 191,893 | $3.95M | 0.00% | +191,893 | New |
| Northern Trust Corp | 195,940 | $4.00M | 0.00% | +195,940 | New |
| Logos Global Management LP | 307,076 | $6.27M | 0.87% | −94,153−23.5% | Reduced |
| Janus Henderson Group PLC | 370,994 | $7.57M | 0.00% | −231,160−38.4% | Reduced |
| Geode Capital Management, LLC | 414,444 | $8.46M | 0.00% | +379,056+1,071.1% | Added |
| State Street Corp | 466,251 | $9.52M | 0.00% | +456,827+4,847.5% | Added |
| Boxer Capital, LLC | 710,644 | $14.5M | 0.67% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 830,983 | $17.0M | 1.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,142,504 | $23.3M | 0.00% | +990,590+652.1% | Added |
| BlackRock Inc. | 1,546,475 | $31.6M | 0.00% | +1,512,680+4,476.0% | Added |
| Cormorant Asset Management, LP | 1,936,133 | $39.5M | 2.25% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,122,465 | $43.3M | 0.82% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 2,124,625 | $43.4M | 6.11% | +199,687+10.4% | Added |
| VR Adviser, LLC | 2,230,127 | $45.5M | 7.28% | +15,985+0.7% | Added |
| Citadel Advisors LLC | 2,296,210 | $46.9M | 0.05% | 00.0% | Unchanged |
| Commodore Capital LP | 2,348,272 | $47.9M | 5.39% | +616,907+35.6% | Added |
| FMR LLC | 4,001,611 | $81.7M | 0.01% | +838,129+26.5% | Added |
| 5AM Venture Management, LLC | 5,798,475 | $118.3M | 29.48% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 8,998,338 | $183.7M | 3.57% | +2,1250.0% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −46,874−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,167−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −11,670−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −8,986−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −746−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −293−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −243−100.0% | Sold out |